Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America

Herpes

Volumn 14, Issue SUPPL. 2, 2007, Pages

  Araújo, Lara Quirino ^a,d   MacIntyre, C Raina ^b   Vujacich, Claudia ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Centro de Estudios Infectologicos   (Argentina)

^d NONE   (Brazil)

Author keywords

Asia; Australia; Disease burden; Herpes zoster; Seroprevalence; South America; Treatment; Vaccination; Varicella

Indexed keywords

VARICELLA ZOSTER VACCINE;

ASIA; AUSTRALIA; CHICKENPOX; CONFERENCE PAPER; HEALTH PROGRAM; HEALTH SURVEY; HERPES ZOSTER; HUMAN; INFECTION PREVENTION; INFECTION RATE; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; SEROPREVALENCE; SOUTH AMERICA; VACCINATION;

ASIA; AUSTRALIA; HERPES ZOSTER; HUMANS; NEURALGIA, POSTHERPETIC; SOUTH AMERICA;

HERPES ZOSTER; HUMAN HERPESVIRUS 3;

EID: 35349014185     PISSN: 09697667     EISSN: 14701537     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Goldman GS. Universal varicella vaccination: efficacy trends and effect on herpes zoster. Int J Toxicol 2005;24:205-213.
2. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD et al. on behalf of the Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-2284.
3. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965;58:9-20.
4. Brisson M, Edmunds WJ. Epidemiology of varicella-zoster virus in England and Wales. J Med Virol 2003;70(Suppl 1):S9-S14.
5. Helgason S, Sigurdsson J, Gudmundsson S. The clinical course of herpes zoster: a prospective study in primary care. Eur J Gen Prac 1996;2:12-16.
6. De Melker H, Berbers G, Hahné S, Rümke H, van den Hof S, de Wit A et al. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine 2006;24:3946-3952.
7. Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplege A et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001;33:62-69.
8. Ragozzino MW, Melton LJ, 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982;61:310-316.
9. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med 1995;155:1605-1609.
10. Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005;20:748-753.
11. Khoshnood B, Debruyne M, Lancon F, Emery C, Fagnani F, Durand I et al. Seroprevalence of varicella in the French population. Pediatr Infect Dis J 2006;25:41-44.
12. Vyse AJ, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect 2004;132:1129-1134.
13. Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 2001;20:121-124.
14. Mossong J, Putz L, Schneider F. Seroprevalence and force of infection of varicella-zoster virus in Luxembourg. Epidemiol Infect 2004;132:1121-1127.
15. Thiry N, Beutels P, Shkedy Z, Vranckx R, Vandermeulen C, Wielen MV. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). Eur J Pediatr 2002;161:588-593.
16. Aebi C, Fischer K, Gorgievski M, Matter L, Muhlemann K. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine 2001;19:3097-3103.
17. Kilgore PE, Kruszon-Moran D, Seward JF, Jumaan A, Van Loon FP, Forghani B et al. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol 2003;70(Suppl 1):S111-S118.
18. Gidding HF, MacIntyre CR, Burgess MA, Gilbert GL. The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiol Infect 2003;131:1085-1089.
19. O'Grady KA, Merianos A, Patel M, Gilbert L. High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climate. Trop Med Int Health 2000;5:732-736.
20. Clemens SA, Azevedo T, Fonseca JC, Silva AC, Silveira TR, Clemens R. Seroepidemiology of varicella in Brazil - results of a prospective cross-sectional study. J Pediatr (Rio J) 1999;75:433-441.
21. Lafer MM, De Moraes-Pinto MI, Weckx LY. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities of Xingu National Park, Brazil, before varicella vaccination. Rev Inst Med Trop Sao Paulo 2005;47:139-142.
22. Dayan GH, Panero MS, Debbag R, Urquiza A, Molina M, Prieto S et al. Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002. J Clin Microbiol 2004;42:5698-5704.
23. Migasena S, Simasathien S, Desakorn V, Phonrat B, Suntharasamai P, Pitisuttitham P et al. Seroprevalence of varicella-zoster virus antibody in Thailand. Int J Infect Dis 1997;2:26-30.
24. Lolekha S, Tanthiphabha W, Sornchai P, Kosuwan P, Sutra S, Warachit B et al. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg 2001;64:131-136.
25. Barzaga NG, Roxas JR, Florese RH. Varicella zoster virus prevalence in Metro Manila, Philippines. J Am Med Assoc (SEAsia) 1994;274:S633- S635.
26. Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J et al. Age related seroprevalence of antibodies to varicella in India. Ind Pediatr 2000;37:714-719.
27. Conway EL, Lenkic C, MacIntyre CR. Herpes Zoster and Associated Health Care Use in General Practice in Australia. Sydney: Public Health Association of Australia 10th National Immunisation Conference, Sydney, Australia, 2006;p50.
28. MacIntyre CR, Chu CP, Burgess MA. Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiol Infect 2003;131:675-682.
29. Brotherton J, McIntyre P, Puech M, Wang H, Gidding H, Hull B et al. Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002. Commun Dis Intell 2004;28(Suppl 2):vii-S116. Available from: 〈http://www.health.gov.au/internet/wcms/publishing.nsf/content/cda- cdi28suppl2c.htm#varicella〉
30. Akram DS, Qureshi H, Mahmud A, Khan AA, Kundi Z, Shafi S et al. Seroepidemiology of varicella-zoster in Pakistan. Southeast Asian J Trop Med Public Health 2000;31:646-649.
31. Garnett GP, Cox MI, Bundy DA, Didier JM, St Catharine J. The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiol Infect 1993;110:361-372.
32. Mandal BK, Mukherjee PP, Murphy C, Mukherjee R, Naik T. Adult susceptibility to varicella in the tropics is a rural phenomenon due to the lack of previous exposure. J Infect Dis 1998;178(Suppl 1):S52-S54.
33. Park SY, Kim JY, Kim CD, Kim CW, Lee KS. A clinical study on herpes zoster during the last 10-year period (1994-2003). Korean J Dermatol 2004;42:1531-1535.
34. Oh HM, Ho AY, Chew SK, Monteiro EH. Clinical presentation of herpes zoster in a Singapore hospital. Singapore Med J 1997;38:471-474.
35. Goh CI, Khoo L. A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int J Dermatol 1997;36:667-672.
36. Alvarez y Munoz MT, Torres J, Damasio-Santana L, Gomez A, Fernandez-Quintanilla G, Tapia-Conyer R et al. Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico. Arch Med Res 1999;30:60-63.
37. Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health 1998;3:886-890.
38. Lazarte Heraud S, Bravo Puccio F, Samalvides Cuba F, Del Solar Chacaltana M, Guerra Amaya O, Verdonck Bosteels K et al. Frecuencia de infección por VIH en pacientes con episodio agudo de herpes zoster (Frequency of HIV infection among adult patients with herpes zoster). Rev Med Hered 2005;16:19-25.
39. Pérez O, Novales LN, Martínez GM, Cantillo JH. Incidencia del herpes zoster en un hospital provincial. Rev Cubana Enferm 2003;19:151-154.
40. Maguiña Vargas C, Bazán L, Alvarez H, Gotuzzo Herencia E, Echevarría Zárate J, Seas Ramos C et al. Estudio retrospectivo de pacientes hospitalizados por herpes zoster en el Hospital Nacional Cayetano Heredia entre los años 1980-1998 (Retrospective study of patients hospitalized by herpes zoster in the Hospital Nacional Cayetano Heredia between the years 1980-1998. Folia Dermatol Peru 1999;10:19-31.
41. Salazar M, Ceron G, Moyano N, Muñoz M. Patologia infecciosa, herpes zoster. Hospital Estatal de Baeza, abr. 1993 (Infectious pathology, herpes zoster, State Hospital of Baeza, April 1993). Rev Méd Cient (Quito) 1997;63-67.
42. Vasconcellos MR, Castro LG, Dos Santos MF. [HIV seropositivity in patients with herpes zoster]. Rev Inst Med Trop Sao Paulo 1999;32:364.
43. Castro LGM, Chen S. Zoster: mas frequentes entre jovens que entre idosos (Zoster: more frequent among youngsters than the aged). An Bras Dermatol 1990;65:129-133.
44. Bargna, MC, Villa R, Ciccarelli A, Parra CA. Epidemiología de infecciones por virus herpes en la década 1972-1981. (Epidemiology of herpesvirus infections in the decade 1972-1981). Rev Argent Dermatol 1985;66:188-193.
45. Gaitan M. Herpes zoster y cancer: relaciones entre estas dos enfermedades. (Herpes zoster and cancer: relationship between these two diseases). Acta Méd Colomb 1981;6:287-293.
46. Reis AD, Pannuti CS, de Souza VA. Prevalence of varicella-zoster virus antibodies in young adults from different Brazilian climatic regions. Rev Soc Bras Med Trop 2003;36:317.